Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$7.84 USD
-0.10 (-1.26%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $7.89 +0.05 (0.64%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.43 | 0.00% |
Earnings Summary
For their last quarter, Recursion Pharmaceuticals (RXRX) reported earnings of -$0.40 per share, beating the Zacks Consensus Estimate of $-0.46 per share. This reflects a positive earnings surprise of 13.04%. Look out for RXRX's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.43 per share, reflecting a year-over-year decrease of 26.47%.
Earnings History
Price & Consensus
Zacks News for RXRX
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
RXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services